HHS Limits Employee Travel

While touting its support for large increases in research funds for the National Institutes of Health (NIH), the Bush administration engaged in a backhanded slap to scientists in all divisions of the Department of Health and Human Services (HHS). In mid-March, Ed Sontag, deputy chief of staff for operations in HHS Secretary Tommy Thompson's office, issued a memo to all HHS divisional staff heads requiring that they "must clear all domestic travel" with his office. International travel for certai

Written byMyrna Watanabe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although these restrictions--including additional restrictions on taking annual leave in conjunction with travel--went nearly unnoticed for several months, by June, members of scientific societies were up in arms, realizing that the rules could have a major impact on scientific meetings. Martin Frank, executive director of the American Physiological Society (APS) in Bethesda, Md., points out that of the approximately 11,000 attendees at their annual spring meeting, 300 came from the NIH. He explained the conundrum of one NIH researcher who was planning to attend an international physiology congress to be held in Christchurch, New Zealand, in August. The researcher is going to a satellite meeting that is a week before the congress. "According to the rules," notes Frank, "he would have to fly back and return to New Zealand by the next meeting" and would be unable to take annual leave days to remain in New Zealand between meetings.

HHS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies